Highlights Roche Holding AG Swiss Exchange

Equities

ROG

CH0012032048

Pharmaceuticals

Real-time Estimate Cboe Europe Other stock markets 17:21:52 13/05/2026 +04			5-day change	1st Jan Change
318.25 ^CHF	-1.01%		+0.94%	-2.93%

09:21am	Roche Holding AG - Analyst/Investor Day
05-12	Roche Receives CE Mark For Elecsys Ptau217 Blood Test For Alzheimer?S Disease Pathology	CI

Highlights

05-12	Roche Receives CE Mark For Elecsys Ptau217 Blood Test For Alzheimer?S Disease Pathology	CI
05-12	Roche CEO Expects Pharma Portfolio to Deliver Sales Growth Through 2030	DJ
05-12	Roche receives CE mark for new blood test to detect Alzheimer's pathology	RE
05-07	Roche Holding AG entered into a definitive merger agreement to acquire PathAI, Inc. for $1.1 billion.	CI
05-07	Switzerland's Roche agrees to acquire US-based PathAI	RE
05-07	Roche to Buy PathAI for Up to $1.05 Billion to Bolster AI Diagnostics Tools	DJ
05-07	Roche Expands With Up to $1 Billion Acquisition of US-based PathAI	MT
05-07	Roche enters to acquire PathAI for $750 million upfront	RE
04-30	Roche Showcases Ophthalmology Portfolio At Arvo 2026	CI
04-29	Zealand Pharma A/S and Roche to Advance Petrelintide, Amylin Analog, to Phase 3 Trials for Chronic Weight Management	CI
04-23	Roche Holding: An assuring start to the year
04-23	Swiss Healthcare Firm Roche Upholds 2026 Guidance as Strong Franc Hits Quarterly Sales	MT
04-23	Roche CEO in interview: U.S. MFN policies are fair, offer needed change to pharma drug pricing systems	RE
04-23	Roche Backs Full-Year View as Quarterly Sales Rise -- Update	DJ
04-23	Roche Backs Full-Year View as Quarterly Sales Rise	DJ
04-23	Roche sales down 5% as currency effects outweigh gains for haemophilia drug	RE
04-23	Roche's Q1 Group Sales Fall; FY26 Outlook Affirmed	MT
04-23	Roche says Q1 sales 14,722 million CHF	RE
04-23	Roche says outlook for 2026 confirmed	RE
04-23	Roche says group sales were +6% at constant exchange rates (CER), -5% when reported in CHF and +9% in USD	RE
04-22	Roche Reports Positive Phase Iii Results for Fenebrutinib in Relapsing Multiple Sclerosis	CI
04-22	Roche submits multiple sclerosis drug fenebrutinib to regulators despite patient deaths	RE
04-21	Roche Announces FDA Acceptance of Application for Gazyva Gazyvaro for Treatment of Systemic Lupus Erythematosus	CI
04-21	Roche Flags US FDA's Acceptance of License Application for Systemic Lupus Erythematosus Drug	MT
04-16	Roche to Buy Cancer-focused Saga Diagnostics for Up to $595 Million	MT